Arvin Dar (@DarArvin) profile picture

Chemical and Structural Biologist. Member and Professor, Chemical Biology Program at MSKCC. Co-Founder Nested Tx.

Joined June 2014
Photo by Arvin Dar (@DarArvin)Photo by Arvin Dar (@DarArvin)Photo by Arvin Dar (@DarArvin)Photo by Arvin Dar (@DarArvin)Photo by Arvin Dar (@DarArvin)
I discuss the urgent crisis from the loss of federal support of science in the US and recent clinical gene editing breakthroughs with @WalterIsaacson & @amanpour on @AmanpourCoPBS, airing on @PBS tonight at 11 pm ET, and on @cnni earlier today. Pls share! youtube.com/watch?v=8YhJM6zx…
915
326
46
1,057
469,081
Wonderful to work with #MSKPostdoc Hiral Mistry...watch for great things from this very talented scientist!
Meet #MSKPostdoc Hiral Mistry (@hiral0809) from the @DarArvin Lab. Hiral aims to reveal new insights into cancer drug sensitivity and resistance by delving into how the Ras-MAPK pathway malfunctions in aggressive cancers through cellular and structural approaches. 🇮🇳#NPAW2024
10
1,038
Amazing Shokat lab reunion weekend... great to see old and new friends!
.@DarArvin passing along words of wisdom at @kevansf lab's dirty thirty. Really cool to see and relive amazing science.
2
28
2,938
Congrats Daniel and colleagues, beautiful work!
Lessons from a Toad Psychedelic about the Role of different Serotonin Receptors in Psychedelic Physiology: nature.com/articles/s41586-0… Congrats to Audrey and @LankriDavidIL in this collab with @SamesLab and @ScottRusso published in @Nature
4
797
Just published with the #AACR24 New Drugs on the Horizon presentation— The pan-RAF-MEK Non-degrading #MolecularGlue NST-628 Is a Potent and Brain-penetrant Inhibitor of the RAS-MAPK Pathway with Activity Across Diverse RAS- and RAF-driven Cancers bit.ly/3Jbh9mh @nestedtx
1
11
2
24
10,711
Congratulations to Klaus Hoeflich and co-authors at @nestedtx on this simultaneous #AACR24 publication in @CD_AACR!
Just published with the #AACR24 New Drugs on the Horizon presentation— The pan-RAF-MEK Non-degrading #MolecularGlue NST-628 Is a Potent and Brain-penetrant Inhibitor of the RAS-MAPK Pathway with Activity Across Diverse RAS- and RAF-driven Cancers bit.ly/3Jbh9mh @nestedtx
5
10
2,222
We are recruiting for a postdoc to join our group at Amgen Oncology in Thousand Oaks, California. This is a great opportunity to learn about drug discovery while having the scientific freedom to engage in curiosity-driven research and publish your results.careers.amgen.com/en/job/tho…
3
25
50
12,086
Congrats to the team at Nested!
We're proud to announce the FDA clearance of our IND Application for NST-628. Additionally, our CSO, will present pre-clinical data on NST-628 at the “New Drugs on the Horizon” Series at the 2024 AACR Annual Meeting. Stay tuned for more updates! nestedtx.com
11
869
Thanks all for voting! You can vote once per day!
Congratulations to Dr. @HellerLab for being accepted into Round 3 of @statnews' #STATMadness. Vote for the team “Shuttling Cancer Drug Across Brain Barrier” now: bit.ly/49WCMCa
9
46
4,104
Congrats Yael!
Thank you so much @MSKCancerCenter for the shoutout!! So proud to be part of the incredible operation at MSKCC💙 Thank you @SloanFoundation for supporting the David lab research! 👩🏻‍🔬💪🏻
1
2
767
Congrats David, Neal and colleagues on such a fantastic review...instant classic on RAF mechanisms and therapeutics!
Great to see this live. Thanks to Aphrothiti Hanrahan and Ziyu Chen as well as David Killock and the editorial staff for their extraordinary efforts. Very optimistic about the new RAF-based therapies in development.
1
730
Wow!
This Post is from an account that no longer exists. Learn more
2
720
Excited to share ‘Live-cell target engagement of allosteric MEKi on MEK-RAF/KSR-14-3-3 complexes’ that we’ve published today in @nchembio! nature.com/articles/s41589-0…
3
7
43
9,295
Have a look! This work was beautifully led by @billymarsiglia, who is now an Assistant Professor at UAB with wonderful contributions by Arthur Chow, Zaigham Khan, and Liu He!
1
349
Thank you to our past and present funders of this work @theNCI @TheMarkFdn
262
Thanks for highlighting our work @CR_AACR! @AmaiaLujambio @GuccioneLab
Read the In the Spotlight commentary— Targeting WNT/β-catenin via modulating EZH2 function, by @XinWang77 and Man Hsin Hung, discussing a @NatureCancer paper from @DarArvin et al. bit.ly/3QnS1gL
6
17
2,678